Related Experiment Video
Updated: Dec 15, 2025
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Integrated Analysis of Transcriptomic Data Reveals Key Anti-CKD Targets and Anti-ESRD Targets
Background:
Chronic kidney disease (CKD) is a kidney disease in which there is gradual loss of kidney function over time and end-stage renal disease (ESRD) is the final stage of CKD. Both CKD and ESRD are worldwide health problems with a high economic cost to health systems. However, the molecular mechanisms of the development of CKD and ESRD remain poorly understood. This study aimed to systematically elucidate the molecular mechanisms of the development of CKD and ESRD.
Methods:
Transcriptome data of CKD and ESRD were downloaded from the NCBI-GEO database. Differentially expressed genes between cases and controls (chronic kidney disease patients vs. controls, end-stage renal disease patients vs. controls) were calculated using the empirical Bayes algorithm. Gene set enrichment analysis (GSEA) was used for analyzing the KEGG pathway difference between cases and controls. Furthermore, CKD and ESRD target genes were obtained from the Thomson Reuters Integrity database. Tissue-specific gene interaction network analysis was performed using the GIANT web server.
Results:
There were multiple damaged pathways in ESRD but only a few pathways were disturbed in CKD. Furthermore, we identified 9 dysregulated anti-ESRD genes but no dysregulated anti-CKD genes. Network analysis revealed that the NF-kB signaling pathway was essential for ESRD.
Conclusions:
This study revealed several crucial anti-ESRD genes that are involved in the regulation of the NF-kB signaling pathway. This information may be helpful for the treatment of ESRD.
Insights
Researchers identified key genes regulating the NF-kB signaling pathway in end-stage renal disease (ESRD), offering potential new treatments for this advanced chronic kidney disease (CKD). This study sheds light on ESRD molecular mechanisms.
Area of Science:
- Nephrology
- Genomics
- Molecular Biology
Background:
- Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are global health issues with significant economic impact.
- The underlying molecular mechanisms driving CKD and ESRD progression are not fully understood.
- This study systematically investigates the molecular underpinnings of CKD and ESRD development.
Purpose of the Study:
- To elucidate the molecular mechanisms involved in the development of chronic kidney disease (CKD).
- To identify key molecular players and pathways implicated in end-stage renal disease (ESRD).
- To uncover potential therapeutic targets for ESRD based on molecular pathway analysis.
Main Methods:
- Downloaded and analyzed transcriptome data for CKD and ESRD from the NCBI-GEO database.
- Identified differentially expressed genes using the empirical Bayes algorithm.
- Performed Gene Set Enrichment Analysis (GSEA) and tissue-specific gene interaction network analysis.
Main Results:
- End-stage renal disease (ESRD) exhibited more pathway disturbances compared to chronic kidney disease (CKD).
- Nine dysregulated genes crucial for anti-ESRD were identified, while no specific anti-CKD genes were found.
- Network analysis highlighted the NF-kB signaling pathway as critical for ESRD.
Conclusions:
- Several key anti-ESRD genes regulating the NF-kB signaling pathway were identified.
- These findings offer valuable insights into the molecular basis of ESRD.
- The identified genes and pathways may serve as potential targets for future ESRD treatments.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
01:25Chronic Kidney Disease I: Introduction